Mei Yangyang, Li Yangmeina, Zhang Bo, Xu Renfang, Feng Xingliang
Department of Urology, Jiangyin People's Hospital Affiliated to Nantong University, Jiangyin, Jiangsu, China.
Department of Otolaryngology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Int J Impot Res. 2024 Jul 4. doi: 10.1038/s41443-024-00945-z.
The C-reactive protein-triglyceride glucose index (CTI) is emerging as a novel indicator for comprehensively assessing the severity of both inflammation and insulin resistance. However, the association between CTI and erectile dysfunction (ED) remains largely unexplored. Participant data for this study were sourced from NHANES 2001-2004, with exclusion criteria applied to those lacking information on clinical variables. The CTI was defined as 0.412*Ln (CRP) + ln [T.G. (mg/dL) × FPG (mg/dL)/2]. Weighted univariable and multivariable logistic regression models were utilized to examine the correlation between the CTI and ED, assessing the CTI as both a continuous and categorical variable (quartile). Moreover, subgroup analyses were conducted to pinpoint sensitive populations, and interaction analysis was performed to validate the findings. A total of 1502 participants were included in the final analysis, encompassing 302 with ED and 1200 without ED. After adjusting for potential confounders, the CTI was positively associated with ED incidence (OR = 1.56, 95% CI: 1.27-1.90, P = 0.002). The fourth quartile of the CTI significantly increased the incidence of ED (OR = 2.69, 95% CI: 1.07-6.74, P = 0.04), and the lowest quartile of CTI was used as the reference. The dose-response curve revealed a positive linear relationship between the CTI and the incidence of ED. Subgroup analysis confirmed the consistent positive relationship between the CTI and ED. The interaction test indicated no significant impact on this association. Finally, a sensitivity analysis was performed to verify the significant positive correlation between the CTI and severe ED (OR = 1.44, 95% CI: 1.19-1.76, P = 0.004). Our national data indicate that a greater CTI is positively linked to an increased risk of ED in US men, suggesting its potential for use in clinical practice for ED prevention or early intervention. Additional large-scale prospective studies are warranted to substantiate the causative relationship between CTI and ED.
C反应蛋白-甘油三酯葡萄糖指数(CTI)正逐渐成为一种用于综合评估炎症和胰岛素抵抗严重程度的新型指标。然而,CTI与勃起功能障碍(ED)之间的关联在很大程度上仍未得到充分研究。本研究的参与者数据来源于2001 - 2004年的美国国家健康与营养检查调查(NHANES),对缺乏临床变量信息的参与者应用了排除标准。CTI被定义为0.412×Ln(CRP)+ ln[甘油三酯(mg/dL)×空腹血糖(mg/dL)/2]。采用加权单变量和多变量逻辑回归模型来检验CTI与ED之间的相关性,将CTI作为连续变量和分类变量(四分位数)进行评估。此外,进行了亚组分析以确定敏感人群,并进行了交互分析以验证研究结果。最终分析共纳入1502名参与者,其中302名患有ED,1200名未患ED。在对潜在混杂因素进行调整后,CTI与ED发病率呈正相关(OR = 1.56,95%CI:1.27 - 1.90,P = 0.002)。CTI的第四个四分位数显著增加了ED的发病率(OR = 2.69,95%CI:1.07 - 6.74,P = 0.04),以CTI的最低四分位数作为参照。剂量反应曲线显示CTI与ED发病率之间存在正线性关系。亚组分析证实了CTI与ED之间始终存在正相关关系。交互检验表明该关联没有显著影响。最后,进行了敏感性分析以验证CTI与重度ED之间存在显著正相关(OR = 1.44,95%CI:1.19 - 1.76,P = 0.004)。我们的全国性数据表明,较高的CTI与美国男性患ED风险增加呈正相关,这表明其在ED预防或早期干预的临床实践中有潜在应用价值。有必要开展更多大规模前瞻性研究来证实CTI与ED之间的因果关系。